ArticleJournal of translational medicine2021

Low CCL19 expression is associated with adverse clinical outcomes for follicular lymphoma patients treated with chemoimmunotherapy.

Yu Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.